ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rite Aid Looks to ‘Ease the Sneeze’ This Allergy Season

On the Hunt to End Seasonal Allergy Suffering, New Data Uncovers Insights on Remedies

It’s no secret seasonal allergies are here. From runny noses and itchy eyes to tissues carried in all pockets and bags, spring has sprung and mother nature has brought the dreaded sneeze with her. To help its suffering shoppers, Rite Aid has spent the last few weeks dusting off last season’s sales data* and speaking with real allergy victims to once and for all ‘Ease the Sneeze.’

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230425006059/en/

B.T.S. (Behind the Sneeze) with Real Allergy Sufferers

With a curiosity for allergy habits, Rite Aid took to the streets to speak with allergy sufferers first-hand to get the 4-1-1 on sneezing, pollen and everything seasonal allergies have to offer – the good, the bad and the ugly.

“Although spring is a time of year many eagerly anticipate, for those with allergies, the season can bring unwelcome health hardships, discomfort and downright frustration,” said Summer Kerley, Dr. of Pharmacy and VP of Clinical Services & Market Access Solutions at Rite Aid. “We strive to find the right relief remedy for our customers. Not only are we offering the tissues and medications, but we’re throwing in a little humor along the way because after all, laughter is the best medicine.”

Spike in Springtime Sniffles

April showers bring May flowers… and also allergies! Last allergy season, Rite Aid shoppers bought nearly one million units of allergy relief medicine in May alone – the highest selling month of the whole allergy season. With blooming blossoms causing an uptick in pollen, there’s no denying that May is the month that consumers are on the highest alert regarding allergy symptoms.

Generic Greatness

There is a common misconception that more often than not, shoppers will reach for a name-brand medication over a generic one because of name recognition, but Rite Aid has proven that not to be true. Last season, approximately 40% of all allergy sufferers looked to Rite Aid’s own allergy medication to relieve their symptoms.

Not only did opting for the generic selection help save their seasonal sorrows, but it also saved their wallets! Consumers who chose the Rite Aid branded allergy medicine over its name-brand counterpart, saved on average 70% more money throughout the entire season on allergy relief products.

Gold, Silver and Bronze of Medicine

While allergy sufferers dispute over alternative remedies to get through the spring months, shopping patterns from last season revealed one mutually agreed upon thing: allergy pills are the favorite of all over-the-counter medicines. According to Rite Aid allergy medication sales, more than three-quarters of all seasonal allergy sufferers prefer the pill form of medication more than any other form. Although pills are chosen by a landslide, an unexpected runner-up is nasal spray medication, beating out liquid dosage forms.

However, fan favorites don’t end at just the type of remedy. The results are in, and the number one medication flavoring is – cherry!

Allergies Call for T.L.C. (Tissues, Loud Sneezes & Candy)

Last allergy season, Rite Aid customers used more than 156 million tissues to blow runny noses and catch sneezes, that’s enough tissue to stretch the entire distance of more than six cross-country road trips!

Beyond tissue needs, shoppers are turning to Rite Aid as their one-stop destination for all allergy season must-haves, as allergy sufferers seek a little extra T.L.C. and something sweet to get them through their various symptoms. According to cart affinity data from last season, candy is the second most included item in carts behind allergy products from March to June, showing consumers look to treat themselves during discomfort with their favorite chocolate and candy delights.

For more information on how to beat seasonal allergies, speak with your local Rite Aid pharmacist for a personalized recommendation or visit www.riteaid.com/wellness/solution-centers/allergy. For all of Rite Aid’s ‘Ease the Sneeze’ content, follow Rite Aid on Facebook, Instagram, Twitter, TikTok, and/or YouTube.

About Rite Aid Corporation

Rite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,300 retail pharmacy locations across 17 states. For more information, visit www.riteaid.com.

*Methodology: Data is approximate and reflects Rite Aid sales of allergy products and other items from March 1 – June 30, 2022

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.54 (0.23%)
AAPL  286.19
+3.09 (1.09%)
AMD  215.24
-4.52 (-2.06%)
BAC  53.19
-0.05 (-0.09%)
GOOG  316.02
+0.90 (0.29%)
META  647.10
+6.23 (0.97%)
MSFT  490.00
+3.26 (0.67%)
NVDA  181.46
+1.54 (0.86%)
ORCL  201.10
+0.16 (0.08%)
TSLA  429.24
-0.90 (-0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.